- Home
- ALNY vs NET Comparison
ALNY vs NET Comparison
Compare ALNY & NET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALNY
- NET
- Stock Information
- Founded
- ALNY 2002
- NET 2009
- Country
- ALNY United States
- NET United States
- Employees
- ALNY N/A
- NET N/A
- Industry
- ALNY Biotechnology: Pharmaceutical Preparations
- NET Computer Software: Prepackaged Software
- Sector
- ALNY Health Care
- NET Technology
- Exchange
- ALNY Nasdaq
- NET Nasdaq
- Market Cap
- ALNY 34.7B
- NET 33.8B
- IPO Year
- ALNY 2004
- NET 2019
- Fundamental
- Price
- ALNY $248.79
- NET $96.46
- Analyst Decision
- ALNY Buy
- NET Hold
- Analyst Count
- ALNY 23
- NET 24
- Target Price
- ALNY $298.59
- NET $93.43
- AVG Volume (30 Days)
- ALNY 958.7K
- NET 3.1M
- Earning Date
- ALNY 10-31-2024
- NET 11-07-2024
- Dividend Yield
- ALNY N/A
- NET N/A
- EPS Growth
- ALNY N/A
- NET N/A
- EPS
- ALNY N/A
- NET N/A
- Revenue
- ALNY $2,094,795,000.00
- NET $1,572,153,000.00
- Revenue This Year
- ALNY $25.14
- NET $29.25
- Revenue Next Year
- ALNY $17.13
- NET $26.61
- P/E Ratio
- ALNY N/A
- NET N/A
- Revenue Growth
- ALNY 21.54
- NET 30.04
- 52 Week Low
- ALNY $141.98
- NET $66.24
- 52 Week High
- ALNY $304.39
- NET $116.00
- Technical
- Relative Strength Index (RSI)
- ALNY 39.68
- NET 60.94
- Support Level
- ALNY $229.86
- NET $87.77
- Resistance Level
- ALNY $271.08
- NET $99.17
- Average True Range (ATR)
- ALNY 9.39
- NET 3.90
- MACD
- ALNY -4.06
- NET 0.29
- Stochastic Oscillator
- ALNY 33.37
- NET 80.03
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
About NET Cloudflare Inc.
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.